Parameter
| Biomarker | IL-1β | Full name | Interleukin 1β | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis, prognosis |
| Disease | BPH | Disease Subtypes | / | ||
| Organ | Prostate | Test Sample / Technology Platform | Urine (Multiplex Microbead immunoassay/ELISA) | ||
| Pathobiological Mechanisms | It serves as the core initiator of inflammatory responses, promoting the release of other inflammatory factors (e.g., IL-6, IL-8) and driving the progression of chronic inflammation, which leads to tissue remodeling and fibrosis. | ||||
| Clinical Availability Status | Research verification | ||||
| Notes and Dynamics | The key biomarker in this study, which was negatively correlated with urinary efficiency, showed a significant decline after treatment, and its change magnitude was closely associated with the improvement of clinical symptoms. | ||||